2-[(E)-3-methoxy-benzenesulfonylimino]-imidazolidine-1-carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester

ID: ALA210949

PubChem CID: 24205511

Max Phase: Preclinical

Molecular Formula: C15H16N6O3S5

Molecular Weight: 488.67

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(S(=O)(=O)NC2=NCCN2C(=S)SN2CCn3c2nsc3=S)c1

Standard InChI:  InChI=1S/C15H16N6O3S5/c1-24-10-3-2-4-11(9-10)29(22,23)18-12-16-5-6-19(12)15(26)28-21-8-7-20-13(21)17-27-14(20)25/h2-4,9H,5-8H2,1H3,(H,16,18)

Standard InChI Key:  QLBZXUCFNVCARB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   12.4227   -5.0796    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1953   -5.3765    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.7146   -4.7356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4680   -4.2584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2668   -4.0424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3082   -3.2173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5356   -2.9204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0163   -3.5652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5397   -4.7771    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.1951   -3.5198    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.7798   -2.8064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9570   -2.8064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1951   -2.0930    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.4706   -2.1400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6853   -2.3950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6853   -3.2178    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4706   -3.4728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7255   -4.2581    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1390   -4.8446    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.7255   -5.4273    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5563   -4.2581    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5563   -5.4273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7636   -5.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1812   -5.7944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3943   -6.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1951   -6.8032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7740   -6.2198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4108   -7.5972    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8310   -8.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  3  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  2  0
  1  2  1  0
 23 24  1  0
  2  3  1  0
 24 25  2  0
  3  5  1  0
 25 26  1  0
  4  1  2  0
 26 27  2  0
 27 22  1  0
  4  5  1  0
 26 28  1  0
  5  6  1  0
 28 29  1  0
M  END

Associated Targets(Human)

KYSE-510 (286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 488.67Molecular Weight (Monoisotopic): 487.9887AlogP: 2.09#Rotatable Bonds: 4
Polar Surface Area: 92.06Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.57CX Basic pKa: 1.71CX LogP: 3.61CX LogD: 3.60
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.64

References

1. Saczewski J, Brzozowski Z, Saczewski F, Bednarski PJ, Liebeke M, Gdaniec M..  (2006)  Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides.,  16  (14): [PMID:16682194] [10.1016/j.bmcl.2006.04.067]

Source